C A R Lok
Overview
Explore the profile of C A R Lok including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
335
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lems E, Leemans J, Lok C, Bongers M, Geomini P
Eur J Obstet Gynecol Reprod Biol
. 2023 Nov;
291:240-246.
PMID: 37939622
Objective: Correct referral of women with an ovarian tumor to an oncology department remains challenging. The International Ovarian Tumor Analysis (IOTA) consortium has developed models with higher diagnostic accuracy than...
2.
Lok C
Int J Radiat Oncol Biol Phys
. 2023 May;
116(2):465-466.
PMID: 37179096
No abstract available.
3.
Frijstein M, Hamers S, van Driel W, Bleiker E, van der Kolk L, Sijstermans R, et al.
Patient Educ Couns
. 2023 May;
113:107786.
PMID: 37148840
Objective: In the Netherlands, patients with ovarian cancer are offered genetic testing. Pre-test preparation may help counseling patients. The aim of this study was to determine if use of a...
4.
Gao Y, Liu C, Li H, Xiong X, Li G, In t Veld S, et al.
Protein Cell
. 2023 Mar;
14(6):579-590.
PMID: 36905391
Platelets are reprogrammed by cancer via a process called education, which favors cancer development. The transcriptional profile of tumor-educated platelets (TEPs) is skewed and therefore practicable for cancer detection. This...
5.
van Stein R, Engbersen M, Stolk T, Lopez-Yurda M, Lahaye M, Beets-Tan R, et al.
Gynecol Oncol
. 2022 Sep;
167(2):269-276.
PMID: 36088169
Objective: Determining whether cytoreductive surgery (CRS) is feasible in patients with advanced ovarian cancer and whether extensive surgery is justified is challenging. Accurate patient selection for CRS based on pre-...
6.
van der Reijd D, Baetens T, Gomez Munoz F, Aarts B, Lahaye M, Graafland N, et al.
Abdom Radiol (NY)
. 2022 Jul;
47(9):3345-3352.
PMID: 35779093
Purpose: To assess the primary safety and oncological outcome of percutaneous cryoablation in patients with non-visceral metastases of the abdominal cavity after prior surgery. Methods: All patients with non-visceral metastases...
7.
Lof P, van de Vrie R, Korse C, van Gent M, Mom C, Rosier-van Dunne F, et al.
Gynecol Oncol
. 2022 Jun;
166(2):284-291.
PMID: 35688656
Introduction: The value of serum human epididymis protein 4 (HE4) in guiding referral decisions in patients with an ovarian mass remains unclear, because the majority of studies investigating HE4 were...
8.
Engbersen M, Lahaye M, Lok C, Koole S, Sonke G, Beets-Tan R, et al.
Eur J Surg Oncol
. 2021 Apr;
47(8):1856-1861.
PMID: 33814239
The extent of peritoneal metastases (PM) largely determines the possibility of complete or optimal cytoreductive surgery in advanced ovarian cancer. An objective scoring system to quantify the extent of PM...
9.
van Baal J, Lok C, Jordanova E, Horlings H, van Driel W, Amant F, et al.
Virchows Arch
. 2020 Dec;
478(3):611.
PMID: 33263796
No abstract available.
10.
van Baal J, Lok C, Jordanova E, Horlings H, van Driel W, Amant F, et al.
Virchows Arch
. 2020 Mar;
477(4):535-544.
PMID: 32179982
Peritoneal metastases of high-grade serous ovarian cancer (HGSOC) are small-sized deposits with superficial growth toward the peritoneal cavity. It is unknown whether integrity of the peritoneal elastic lamina (PEL) correlates...